Bcl-2 antisense oligodeoxynucleotide (Genasense) enhances gemtuzumab ozogamicin (Mylotarg)-induced cytotoxicity in acute myeloid leukemia. Khodadoust, M., Konopleva, M., Leysath, C., Frankel, Giles, F. J., Andreeff, M. AMER SOC HEMATOLOGY. 2001: 102A

View details for Web of Science ID 000172134100430